Brazil Cardiac Resynchronization Therapy Market Size & Outlook
Brazil cardiac resynchronization therapy market, 2018-2030 (US$M)
Related Markets
Brazil cardiac resynchronization therapy market highlights
- The Brazil cardiac resynchronization therapy market generated a revenue of USD 58.1 million in 2023 and is expected to reach USD 83.1 million by 2030.
- The Brazil market is expected to grow at a CAGR of 5.2% from 2024 to 2030.
- In terms of segment, crt-defibrillator was the largest revenue generating product in 2023.
- CRT-Pacemaker is the most lucrative product segment registering the fastest growth during the forecast period.
Cardiac resynchronization therapy market data book summary
| Market revenue in 2023 | USD 58.1 million |
| Market revenue in 2030 | USD 83.1 million |
| Growth rate | 5.2% (CAGR from 2023 to 2030) |
| Largest segment | Crt-defibrillator |
| Fastest growing segment | CRT-Pacemaker |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CRT-Defibrillator, CRT-Pacemaker |
| Key market players worldwide | Medtronic PLC, Abbott Laboratories, Boston Scientific Corp, BIOTRONIK, MicroPort Scientific Corp, LivaNova PLC |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.3% of the global cardiac resynchronization therapy market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil cardiac resynchronization therapy market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 70.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cardiac Resynchronization Therapy Market Scope
Cardiac Resynchronization Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil cardiac resynchronization therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac resynchronization therapy market will help companies and investors design strategic landscapes.
Crt-defibrillator was the largest segment with a revenue share of 53.36% in 2023. Horizon Databook has segmented the Brazil cardiac resynchronization therapy market based on crt-defibrillator, crt-pacemaker covering the revenue growth of each sub-segment from 2018 to 2030.
In Brazil, the average annual growth in healthcare expenditure was USD 848.29 per capita in 2018, which is likely to boost this market. In addition, healthcare spending in Brazil accounted for 9.5% of its GDP, which is the second-largest in Latin America after Cuba. Such factors are expected to promote market growth in the country.
According to BioMed Central Ltd, 10% of all hospital admissions were due to CVDs from 2008 to 2017 in Brazil. Moreover, increase in factors such as overall tobacco smoking population and the prevalence of hypertension has augmented the risk of CVD-related deaths. For instance, according to Macrotrends LLC, smoking rate in Brazil was 16.5% in 2018, which increases the risk of cardiac arrest.
Reasons to subscribe to Brazil cardiac resynchronization therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil cardiac resynchronization therapy market databook
-
Our clientele includes a mix of cardiac resynchronization therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil cardiac resynchronization therapy market , including forecasts for subscribers. This country databook contains high-level insights into Brazil cardiac resynchronization therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil cardiac resynchronization therapy market size, by product, 2018-2030 (US$M)
Brazil Cardiac Resynchronization Therapy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
